Global Patent Medicine Sales Market Report 2021

1 Patent Medicine Market Overview

• 1.1 Patent Medicine Product Scope
• 1.2 Patent Medicine Segment by Type
  • 1.2.1 Global Patent Medicine Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Product Patents
  • 1.2.3 Process Patents
• 1.3 Patent Medicine Segment by Application
  • 1.3.1 Global Patent Medicine Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Adult
  • 1.3.3 Children
• 1.4 Patent Medicine Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Patent Medicine Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Patent Medicine Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Patent Medicine Price Trends (2016-2027)

2 Patent Medicine Estimates and Forecasts by Region

• 2.1 Global Patent Medicine Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Patent Medicine Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Patent Medicine Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Patent Medicine Revenue Market Share by Region (2016-2021)
• 2.3 Global Patent Medicine Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Patent Medicine Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Patent Medicine Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Patent Medicine Estimates and Projections (2016-2027)
  • 2.4.2 Europe Patent Medicine Estimates and Projections (2016-2027)
  • 2.4.3 China Patent Medicine Estimates and Projections (2016-2027)
  • 2.4.4 Japan Patent Medicine Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Patent Medicine Estimates and Projections (2016-2027)
  • 2.4.6 India Patent Medicine Estimates and Projections (2016-2027)

3 Global Patent Medicine Competition Landscape by Players

• 3.1 Global Top Patent Medicine Players by Sales (2016-2021)
• 3.2 Global Top Patent Medicine Players by Revenue (2016-2021)
• 3.3 Global Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Patent Medicine as of 2020)
• 3.4 Global Patent Medicine Average Price by Company (2016-2021)
• 3.5 Manufacturers Patent Medicine Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Patent Medicine Market Size by Type

• 4.1 Global Patent Medicine Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Patent Medicine Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Patent Medicine Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Patent Medicine Price by Type (2016-2021)
• 4.2 Global Patent Medicine Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Patent Medicine Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Patent Medicine Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Patent Medicine Price Forecast by Type (2022-2027)

5 Global Patent Medicine Market Size by Application

• 5.1 Global Patent Medicine Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Patent Medicine Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Patent Medicine Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Patent Medicine Price by Application (2016-2021)
• 5.2 Global Patent Medicine Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Patent Medicine Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Patent Medicine Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Patent Medicine Price Forecast by Application (2022-2027)

6 North America Patent Medicine Market Facts & Figures

• 6.1 North America Patent Medicine Sales by Company
  • 6.1.1 North America Patent Medicine Sales by Company (2016-2021)
  • 6.1.2 North America Patent Medicine Revenue by Company (2016-2021)
• 6.2 North America Patent Medicine Sales Breakdown by Type
  • 6.2.1 North America Patent Medicine Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Patent Medicine Sales Breakdown by Type (2022-2027)
• 6.3 North America Patent Medicine Sales Breakdown by Application
  • 6.3.1 North America Patent Medicine Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Patent Medicine Sales Breakdown by Application (2022-2027)

7 Europe Patent Medicine Market Facts & Figures

• 7.1 Europe Patent Medicine Sales by Company
  • 7.1.1 Europe Patent Medicine Sales by Company (2016-2021)
  • 7.1.2 Europe Patent Medicine Revenue by Company (2016-2021)
• 7.2 Europe Patent Medicine Sales Breakdown by Type
  • 7.2.1 Europe Patent Medicine Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Patent Medicine Sales Breakdown by Type (2022-2027)
• 7.3 Europe Patent Medicine Sales Breakdown by Application
  • 7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)

8 China Patent Medicine Market Facts & Figures

• 8.1 China Patent Medicine Sales by Company
  • 8.1.1 China Patent Medicine Sales by Company (2016-2021)
  • 8.1.2 China Patent Medicine Revenue by Company (2016-2021)
• 8.2 China Patent Medicine Sales Breakdown by Type
  • 8.2.1 China Patent Medicine Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Patent Medicine Sales Breakdown by Type (2022-2027)
• 8.3 China Patent Medicine Sales Breakdown by Application
  • 8.3.1 China 240 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 240 Sales Breakdown by Application (2022-2027)

9 Japan Patent Medicine Market Facts & Figures

• 9.1 Japan Patent Medicine Sales by Company
  • 9.1.1 Japan Patent Medicine Sales by Company (2016-2021)
  • 9.1.2 Japan Patent Medicine Revenue by Company (2016-2021)
• 9.2 Japan Patent Medicine Sales Breakdown by Type
  • 9.2.1 Japan Patent Medicine Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Patent Medicine Sales Breakdown by Type (2022-2027)
• 9.3 Japan Patent Medicine Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Patent Medicine Market Facts & Figures

• 10.1 Southeast Asia Patent Medicine Sales by Company
  • 10.1.1 Southeast Asia Patent Medicine Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Patent Medicine Revenue by Company (2016-2021)
• 10.2 Southeast Asia Patent Medicine Sales Breakdown by Type
  • 10.2.1 Southeast Asia Patent Medicine Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Patent Medicine Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Patent Medicine Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)

11 India Patent Medicine Market Facts & Figures

• 11.1 India Patent Medicine Sales by Company
  • 11.1.1 India Patent Medicine Sales by Company (2016-2021)
  • 11.1.2 India Patent Medicine Revenue by Company (2016-2021)
• 11.2 India Patent Medicine Sales Breakdown by Type
  • 11.2.1 India Patent Medicine Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Patent Medicine Sales Breakdown by Type (2022-2027)
• 11.3 India Patent Medicine Sales Breakdown by Application
  • 11.3.1 India Patent Medicine Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Patent Medicine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Patent Medicine Business

• 12.1 Pfizer Inc.
  • 12.1.1 Pfizer Inc. Corporation Information
  • 12.1.2 Pfizer Inc. Business Overview
  • 12.1.3 Pfizer Inc. Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Pfizer Inc. Patent Medicine Products Offered
  • 12.1.5 Pfizer Inc. Recent Development
• 12.2 Otsuka Pharmaceutical
  • 12.2.1 Otsuka Pharmaceutical Corporation Information
  • 12.2.2 Otsuka Pharmaceutical Business Overview
  • 12.2.3 Otsuka Pharmaceutical Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Otsuka Pharmaceutical Patent Medicine Products Offered
  • 12.2.5 Otsuka Pharmaceutical Recent Development
• 12.3 Merck
  • 12.3.1 Merck Corporation Information
  • 12.3.2 Merck Business Overview
  • 12.3.3 Merck Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Merck Patent Medicine Products Offered
  • 12.3.5 Merck Recent Development
• 12.4 Novartis
  • 12.4.1 Novartis Corporation Information
  • 12.4.2 Novartis Business Overview
  • 12.4.3 Novartis Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Novartis Patent Medicine Products Offered
  • 12.4.5 Novartis Recent Development
• 12.5 Sanofi-Aventis
  • 12.5.1 Sanofi-Aventis Corporation Information
  • 12.5.2 Sanofi-Aventis Business Overview
  • 12.5.3 Sanofi-Aventis Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Sanofi-Aventis Patent Medicine Products Offered
  • 12.5.5 Sanofi-Aventis Recent Development
• 12.6 Bristol-Myers Squibb Co.
  • 12.6.1 Bristol-Myers Squibb Co. Corporation Information
  • 12.6.2 Bristol-Myers Squibb Co. Business Overview
  • 12.6.3 Bristol-Myers Squibb Co. Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Bristol-Myers Squibb Co. Patent Medicine Products Offered
  • 12.6.5 Bristol-Myers Squibb Co. Recent Development
• 12.7 GSK
  • 12.7.1 GSK Corporation Information
  • 12.7.2 GSK Business Overview
  • 12.7.3 GSK Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 GSK Patent Medicine Products Offered
  • 12.7.5 GSK Recent Development

...

13 Patent Medicine Manufacturing Cost Analysis

• 13.1 Patent Medicine Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Patent Medicine
• 13.4 Patent Medicine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Patent Medicine Distributors List
• 14.3 Patent Medicine Customers

15 Market Dynamics

• 15.1 Patent Medicine Market Trends
• 15.2 Patent Medicine Drivers
• 15.3 Patent Medicine Market Challenges
• 15.4 Patent Medicine Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List